Company: PFSA
Filing Date: 2025-05-13
Form Type: S-4/A
Source: 0001213900-25-042224
Chunk: 247

Company: Profusa, Inc.
Filing Date: 2025-05-13
Form: S-4/A
Chunk 247
---
 and thereby increase the value of Profusa and its affiliates’ holdings and their return on investment in Profusa. The diluted ownership percentages referenced above include the dilution from the PIPE Subscription Agreement. Public Shareholders.For the Public Shareholders of NorthView, the Business Combination represents the opportunity to share in the growth of a company such as Profusa that was chosen by the management of NorthView as an acquisition target in an initial business combination (which was NorthView’s original purpose). Unlike the NorthView Insiders, if an initial business combination was not consummated by NorthView within the required time period, the Public Shareholders would receive a pro -rataportion of the trust account, equivalent to their initial investment plus interest. Like the NorthView Insiders, however, the NorthView Rights and NorthView Warrants held by the Public Shareholders would expire worthless if no business combination such as the Business Combination is completed by the deadline. The potential detriment of the PIPE Subscription Agreement to the Sponsor and its affiliates is that the shares of New Profusa Common Stock that may be issued to the PIPE Investors upon the conversion of the PIPE Convertible Notes would dilute the ownership percentage of the Sponsor by between approximately 6.2% (assuming no redemption of NorthView Common Stock by Public Stockholders) and approximately 5.8% (assuming maximum redemption NorthView Common Stock by Public Stockholders), not including any NorthView Common stock that could be issued pursuant to the PIPE Subscription Agreement for the additional tranches of PIPE Convertible Notes. The potential PIPE Subscription Agreement benefits New Profusa by providing it with additional capital that could fund New Profusa’s operations and growth following the Business Combination, and thereby increase the value of New Profusa and the Public Shareholders’ holdings and their return on investment in NorthView. The diluted ownership percentages referenced above include the dilution from the PIPE Subscription Agreement. Ownership of New Profusa As of the date of this proxy statement/prospectus, there are 5,348,311shares of NorthView Common Stock issued and outstanding, which includes an aggregate of 4,743,750shares of NorthView Common Stock held by the Sponsor. In addition, as of the date of this proxy statement/prospectus, there is outstanding an aggregate of 17,404,250 warrants to acquire NorthView Common Stock, comprised of 7,347,500 private placement warrants held by the Sponsor and Representatives, 9,487,500 public warrants, and 569,250 Representative Warrants. Each whole warrant will ent